Nordic NeuroSTIM

Nordic NeuroSTIM operates in the neuroscience, rehabilitation, and therapeutics categories, with a focused offering for gait rehabilitation after stroke. Its described approach combines an insole-based foot switch and electrodes with a control unit that times electrical stimulation to the moment a patient lifts a foot during gait training. The Incedo™ system is intended to augment existing rehabilitation methods, distinguishing the company’s stated approach through reflex-timed stimulation rather than a broad digital-health or general-purpose medical-device proposition. The company’s stated differentiators also include collaboration with clinicians and a focus on practical rehabilitation needs. The company’s reported scale is small, at 1–10 employees, and the available funding history consists of one $927,055 Seed round in 2013. These details suggest a specialist medical-device profile, but there is insufficient current information to assess market share, clinical adoption, or relative commercial scale against other neurorehabilitation providers.

Nordic NeuroSTIM was founded in 2013 and raised a $927,055 Seed round on Mar 7, 2013, led by Seed Capital. That early financing is the only funding round listed, leaving a long gap in the available funding history through Oct 7, 2026. The company’s product information identifies Incedo™ as a reflex-based electrical therapy system for walking rehabilitation, designed to support stroke patients during gait training. The approach is presented as an augmentation to existing rehabilitation methods, with stimulation timed to foot movement. The company is listed as active and has a reported employee range of 1–10, with Christian Christiansen identified as CEO and Managing Director and Jon Ingi Benediktsson as Chairman. On the evidence available, the trajectory is characterized by early seed financing and a focused rehabilitation product, while its more recent commercial development, clinical reach, and growth rate remain unclear.